Publications by authors named "Qiao-yun Chen"

Objective: To investigate whether single nucleotide polymorphisms (SNPs) in the 3' untranslated region (UTR) of the matrix metallopeptidase 9 gene () are associated with susceptibility to calcium oxalate stones.

Methods: A total of 428 patients with kidney stone disease (KSD) and 450 control individuals were enrolled. Three SNPs (rs20544, rs9509, and rs1056628) were genotyped, and mRNA and protein expression was determined in patients and controls.

View Article and Find Full Text PDF

Haploinsufficiency of the runt-related transcription factor 2 (Runx2) gene is widely known to be responsible for cleidocranial dysplasia (CCD). To date, more than 190 mutations in Runx2 gene have been reported to be related to CCD. In this study, a novel mutation of Runx2 gene was observed in a female with CCD.

View Article and Find Full Text PDF

This study was aimed to evaluate the effect of triptolide (TPL) on the reversal of multidrug resistance in K562/A02 cell line. The sensitivity of K562 and K562/A02 to adriamycin (ADM) and reversal of drug resistance were determined with MTT method. The concentration of intracellular ADM and P-glycoprotein expression were detected by flow cytometry.

View Article and Find Full Text PDF

Objective: To investigate the effect of YB-1 on the transcription of induced mdr1 gene expression in K562 cells.

Methods: K562 cells were treated with doxorubicin (DOX) at different concentrations and times. Expression of mdr1 and YB-1 genes was examined by RT-PCR and P-glycoprotein (P-gp) by flow cytometry.

View Article and Find Full Text PDF
Article Synopsis
  • - This study investigates how tetrandrine (TTD) can prevent multidrug resistance (MDR) caused by doxorubicin (ADM) in human leukemia cells by looking at genetic factors and cell death processes.
  • - The experimental groups included a control group, a drug-resistant group induced by ADM, and a group pre-treated with TTD, with various tests conducted to assess gene expression and apoptosis rates.
  • - Results showed that TTD improved gene expression related to apoptosis and reduced the levels of MDR1, suggesting it effectively enhances the efficacy of doxorubicin in treating leukemia.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigated how introducing YB-1 shRNA into K562/A02 leukemia cells affects cell growth, apoptosis (cell death), and their sensitivity to anticancer drugs.
  • Researchers used techniques like RT-PCR, Western blot, and MTT assays to measure changes in gene and protein expression, cell proliferation, and drug sensitivity after the transfection.
  • Results showed that reducing YB-1 expression led to decreased cell growth, increased apoptosis rates, and higher sensitivity to doxorubicin, indicating the potential of YB-1 shRNA in improving leukemia treatment.
View Article and Find Full Text PDF

This study was aimed to explore the effect of vascular endothelial growth factor (VEGF) on sensitivity of leukemia cell line K562/A02 to doxorubicin by using RNA interference, and to investigate its mechanism. The 3 shRNA targeting human vegf gene were synthesized, then transfected into K562/A02 cells by lipofectamine 2000 reagent. RT-PCR was used to detect the expression of vegf and mrp1 at the mRNA level;Western blot was used to analyze the expression of VEGF, MRP1, AKT, P-AKT at the protein level; MTT was used to determine the IC(50) value of transfected cells to doxorubicin (DOX); flow cytometry was used to detect cell apoptosis and intracellular Rho123 retention.

View Article and Find Full Text PDF

Purpose: To investigate the preventive effect of celecoxib, a specific cyclooxygenase-2 (Cox-2) inhibitor, on the development of chemoresistance in breast cancer cell line, MCF-7, and explore the mechanism of the action.

Methods: Chemoresistance phenotype was established by treating MCF-7 cells with 0.05 μg/ml doxorubicin for 7 days, and then the effect of preventive chemoresistance was investigated by the combination of same dose of doxorubicin with 10 μM celecoxib.

View Article and Find Full Text PDF

Objective: To evaluate the impact of a new CD44 variant on invasion of human breast cancer cell line MCF-7, and its possible mechanisms.

Methods: The full length cDNA encoding CD44v17 was obtained from the total RNA isolated from the MCF-7/ADR cells by reverse transcript-polymerase chain reaction (RT-PCR) and subcloned into pMD19-T vector. The CD44v17 gene sequence and reading frame were confirmed by two restriction enzymes and nucleotide sequencing, and then inserted into the eukaryotic expression vector pcDNA3.

View Article and Find Full Text PDF

Objective: To investigate the potential effects of YB-1 gene knockdown on gene expression profile, cell growth and apoptosis in leukemia cell line K562/A02.

Methods: The recombinant eukaryotic expression plasmid containing YB-1 short hairpin RNA (shRNA) or random-sequence (HK) were transfected into K562/A02 cells by lipofectamine mediation. cDNA microarray was performed to explore the alteration of gene expression profile when YB-1 gene expression was decreased.

View Article and Find Full Text PDF

Objective: To investigate the effect of tetrandrine (TTD) on doxorubicin-induced mdr1 gene expression and its mechanism.

Methods: MTT assay was used to detect the cytotoxicity of TTD to K562 cells. K562 cells were treated with doxorubicin alone or 0.

View Article and Find Full Text PDF

Objective: Herein we aim to test if pummelo furanocoumarins can inhibit cytochrome P450 (CYP) 3A both in vitro and in vivo, and to explore the influence of CYP3A5*3 (GenBank AC005020: A22893-->G) polymorphism in the pharmacokinetics and pharmacological response to felodipine.

Method: Fruit juices of pummelo grapefruit (Citrus paradisi Macf., G), 'Guanximiyou' (C.

View Article and Find Full Text PDF